Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1121

1.

Comparison of Single Intra-Articular Injection of Novel Hyaluronan (HYA-JOINT Plus) with Synvisc-One for Knee Osteoarthritis: A Randomized, Controlled, Double-Blind Trial of Efficacy and Safety.

Sun SF, Hsu CW, Lin HS, Liou IH, Chen YH, Hung CL.

J Bone Joint Surg Am. 2017 Mar 15;99(6):462-471. doi: 10.2106/JBJS.16.00469.

PMID:
28291178
2.

Reduced risk of all-cancer and solid cancer in Taiwanese patients with rheumatoid arthritis treated with etanercept, a TNF-α inhibitor.

Lan JL, Tseng CH, Chen JH, Cheng CF, Liang WM, Tsay GJ.

Medicine (Baltimore). 2017 Feb;96(7):e6055. doi: 10.1097/MD.0000000000006055.

3.

Treatment strategy of elderly rheumatoid arthritis.

Takeda T.

Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(6):497-504. doi: 10.2177/jsci.39.497. Review.

4.
5.

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.

Nissen SE, Yeomans ND, Solomon DH, Lüscher TF, Libby P, Husni ME, Graham DY, Borer JS, Wisniewski LM, Wolski KE, Wang Q, Menon V, Ruschitzka F, Gaffney M, Beckerman B, Berger MF, Bao W, Lincoff AM; PRECISION Trial Investigators.

N Engl J Med. 2016 Dec 29;375(26):2519-29. doi: 10.1056/NEJMoa1611593. Epub 2016 Nov 13.

PMID:
27959716
6.

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor: A novel treatment option for nurse practitioners treating patients with psoriatic disease.

Young M, Roebuck HL.

J Am Assoc Nurse Pract. 2016 Dec;28(12):683-695. doi: 10.1002/2327-6924.12428. Epub 2016 Nov 21.

7.

Differences in analgesic use in community-dwelling persons with and without Alzheimer's disease.

Hamina A, Taipale H, Tanskanen A, Tolppanen AM, Tiihonen J, Hartikainen S.

Eur J Pain. 2017 Apr;21(4):658-667. doi: 10.1002/ejp.969. Epub 2016 Nov 14.

PMID:
27862681
8.

Long-term drug survival and clinical effectiveness of etanercept treatment in patients with ankylosing spondylitis in daily clinical practice.

Arends S, Brouwer E, Efde M, van der Veer E, Bootsma H, Wink F, Spoorenberg A.

Clin Exp Rheumatol. 2017 Jan-Feb;35(1):61-68. Epub 2016 Oct 7.

PMID:
27749222
9.

The effect and safety of highly standardized Ginger (Zingiber officinale) and Echinacea (Echinacea angustifolia) extract supplementation on inflammation and chronic pain in NSAIDs poor responders. A pilot study in subjects with knee arthrosis.

Rondanelli M, Riva A, Morazzoni P, Allegrini P, Faliva MA, Naso M, Miccono A, Peroni G, Degli Agosti I, Perna S.

Nat Prod Res. 2017 Jun;31(11):1309-1313. doi: 10.1080/14786419.2016.1236097. Epub 2016 Oct 13.

PMID:
27737573
10.

Safety and efficacy of etanercept and adalimumab in children aged 2 to 4 years with juvenile idiopathic arthritis.

Windschall D, Horneff G.

Clin Rheumatol. 2016 Dec;35(12):2925-2931. Epub 2016 Oct 5.

PMID:
27709443
11.

The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis.

Deodhar A, Bitman B, Yang Y, Collier DH.

Clin Rheumatol. 2016 Dec;35(12):3045-3052. Epub 2016 Oct 5.

12.

Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial.

Verschueren P, De Cock D, Corluy L, Joos R, Langenaken C, Taelman V, Raeman F, Ravelingien I, Vandevyvere K, Lenaerts J, Geens E, Geusens P, Vanhoof J, Durnez A, Remans J, Vander Cruyssen B, Van Essche E, Sileghem A, De Brabanter G, Joly J, Meyfroidt S, Van der Elst K, Westhovens R.

Ann Rheum Dis. 2017 Mar;76(3):511-520. doi: 10.1136/annrheumdis-2016-209212. Epub 2016 Jul 18.

PMID:
27432356
13.

Apremilast in the therapy of moderate-to-severe chronic plaque psoriasis.

Gisondi P, Girolomoni G.

Drug Des Devel Ther. 2016 May 25;10:1763-70. doi: 10.2147/DDDT.S108115. eCollection 2016. Review.

14.

The Long-Term Safety of S-Flurbiprofen Plaster for Osteoarthritis Patients: An Open-Label, 52-Week Study.

Yataba I, Otsuka N, Matsushita I, Matsumoto H, Hoshino Y.

Clin Drug Investig. 2016 Aug;36(8):673-82. doi: 10.1007/s40261-016-0412-0.

15.

Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial.

Porter D, van Melckebeke J, Dale J, Messow CM, McConnachie A, Walker A, Munro R, McLaren J, McRorie E, Packham J, Buckley CD, Harvie J, Taylor P, Choy E, Pitzalis C, McInnes IB.

Lancet. 2016 Jul 16;388(10041):239-47. doi: 10.1016/S0140-6736(16)00380-9. Epub 2016 May 17.

PMID:
27197690
16.

Gastrointestinal safety and efficacy of long-term GCSB-5 use in patients with osteoarthritis: A 24-week, multicenter study.

Ha CW, Park YB, Kyung HS, Han CS, Bae KC, Lim HC, Park SE, Lee MC, Won YY, Lee DC, Cho SD, Kim CW, Kim JG, Kang JS, Lee JH, Choi ES, Seon JK, Lee WS, Bin SI.

J Ethnopharmacol. 2016 Aug 2;189:310-8. doi: 10.1016/j.jep.2016.05.031. Epub 2016 May 16.

17.

Efficacy of S-flurbiprofen plaster in knee osteoarthritis treatment: Results from a phase III, randomized, active-controlled, adequate, and well-controlled trial.

Yataba I, Otsuka N, Matsushita I, Matsumoto H, Hoshino Y.

Mod Rheumatol. 2017 Jan;27(1):130-136. doi: 10.1080/14397595.2016.1176624. Epub 2016 May 11.

PMID:
27168463
18.

Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers.

Hellgren K, Dreyer L, Arkema EV, Glintborg B, Jacobsson LT, Kristensen LE, Feltelius N, Hetland ML, Askling J; ARTIS Study Group, For the DANBIO Study Group.

Ann Rheum Dis. 2017 Jan;76(1):105-111. doi: 10.1136/annrheumdis-2016-209270. Epub 2016 May 4.

PMID:
27147709
19.

Efficacy and short-term safety of topical Dwarf Elder (Sambucus ebulus L.) versus diclofenac for knee osteoarthritis: A randomized, double-blind, active-controlled trial.

Jabbari M, Hashempur MH, Razavi SZ, Shahraki HR, Kamalinejad M, Emtiazy M.

J Ethnopharmacol. 2016 Jul 21;188:80-6. doi: 10.1016/j.jep.2016.04.035. Epub 2016 Apr 26.

PMID:
27125590
20.

Tolerability of the COX-1/COX-2 inhibitor lornoxicam in the treatment of acute and rheumatic pain.

Parada L, Marstein JP, Danilov A.

Pain Manag. 2016 Oct;6(5):445-54. doi: 10.2217/pmt.16.7. Epub 2016 Apr 18.

PMID:
27086708

Supplemental Content

Loading ...
Support Center